Align Technology (ALGN) News Today

Rhumbline Advisers decreased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 3.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 139,971 shares of the medical equipment prov

Principal Financial Group Inc. decreased its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 38.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 79,852 shares of the medical equip

Panagora Asset Management Inc. decreased its stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 96.5% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,572 shares of the medical equipment provider's stock after sel

Versor Investments LP raised its stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 385.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,139 shares of the medical equipment provider's stock af

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 8,933 shares of the medical equ

Davidson Investment Advisors raised its stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 9.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 44,073 shares of the medical equipment provider's s

Align Technology, Inc. (NASDAQ:ALGN - Get Free Report) saw a large increase in short interest in August. As of August 15th, there was short interest totalling 2,730,000 shares, an increase of 21.9% from the July 31st total of 2,240,000 shares. Currently, 3.9% of the shares of the stock are short sold. Based on an average daily volume of 880,300 shares, the short-interest ratio is presently 3.1 days.

Raymond James & Associates lessened its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 41.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,044 shares of the medical equipment provider's stock after selling 12

Allspring Global Investments Holdings LLC lowered its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 3.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 68,453 shares of the m

Align Technology (NASDAQ:ALGN) Trading Up 2.8%

ARK Investment Management LLC trimmed its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 23.7% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,091 shares of the medical equipment provider's stock after selling 1,895 shares during the

Banque Pictet & Cie SA increased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 86.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 23,269 shares of the medical equipment provider's stock after purchasing an additional 1

Bank Pictet & Cie Europe AG acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,218 shares of the medical equipment provider's stock, valued at app

StockNews.com upgraded Align Technology from a "hold" rating to a "buy" rating in a research report on Saturday.

New York State Teachers Retirement System lowered its position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 4.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 77,679 shares of t

Align Technology, Inc. (NASDAQ:ALGN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the ten research firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a

Lecap Asset Management Ltd. reduced its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 46.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,223 shares of the medical equipment provider's stock after selling

Align Technology, Inc. (NASDAQ:ALGN - Get Free Report) Director C Raymond Larkin, Jr. acquired 6,500 shares of Align Technology stock in a transaction that occurred on Thursday, August 15th. The stock was purchased at an average cost of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the purchase, the director now owns 28,247 shares in the company, valued at approximately $6,647,366.51. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Sumitomo Mitsui Trust Holdings Inc. decreased its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 6.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 163,411 shares of the medical equipment prov

Align Technology, Inc. (NASDAQ:ALGN - Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 2,240,000 shares, a growth of 6.2% from the July 15th total of 2,110,000 shares. Based on an average daily trading volume, of 860,300 shares, the short-interest ratio is presently 2.6 days. Approximately 3.2% of the shares of the company are short sold.

Swedbank AB grew its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 2.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 299,115 shares of the medical equipment provider's stock af

StockNews.com downgraded Align Technology from a "buy" rating to a "hold" rating in a report on Friday.

Assenagon Asset Management S.A. grew its position in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 339.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 73,494 shares of the medical equipment provider's stock after buying a

Cetera Investment Advisers lifted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 914.2% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,627 shares of the medical equipment provider's stock after purc

AMF Tjanstepension AB purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 22,492 shares of the medical equipme

DNB Asset Management AS cut its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 41.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,290 shares of the medic